All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Formulary
Back
Contact us about this page
Urinary tract infections (UTI)
Toggle Pages
Management of asymptomatic bacteriuria (ASB)
Management of catheter-associated urinary tract infection (CA-UTI)
Management of chronic pelvic pain syndrome (CPPS)
Management of community multidrug-resistant (MDR) urinary tract infection (UTI)
Management of lower urinary tract infections (UTI)
Management of prostatitis, acute
Management of pyelonephritis, acute
Management of recurrent urinary tract infection (rUTI)
Resources for urinary tract infections (UTI)
Chapter 5: Infections
Toggle Parent Pages
Print this page
Principles of antibacterial treatment
Coronavirus disease (COVID-19)
Eye infections
Gastro-intestinal tract infections
Genital tract infections
Meningitis
Respiratory tract infections (RTI)
Skin and soft tissue infections
Oral and dental infections
Urinary tract infections (UTI)
5.1 Antibacterial drugs
5.2 Antifungal drugs
5.3 Antiviral drugs
5.4 Antiprotozoal drugs
5.5 Anthelmintics
Contact us about this page
Management of community multidrug-resistant (MDR) urinary tract infection (UTI)
First Line
Second Line
Specialist
Hospital Only
If released on a urine sensitivity report then consider the following i.e. not for empirical use
Pivmecillinam
- Initially 400mg for one dose, then 200mg every 8 hours for 3 days in women, 7 days in men
- This is an extended-spectrum penicillin antibiotic
If high risk of resistance
Fosfomycin
- Female: 3g sachet as a single dose (dose may be repeated in complicated UTI; unlicensed)
- Male: 3g sachet initial dose and repeat after 3 days (unlicensed but in line with PHE guidance)
- Doses should be taken preferably before bedtime and after emptying the bladder
